167 related articles for article (PubMed ID: 37095025)
1. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
Jørgensen MG; Gözeri E; Petersen TG; Sørensen JA
Clin Breast Cancer; 2023 Jul; 23(5):e296-e304.e2. PubMed ID: 37095025
[TBL] [Abstract][Full Text] [Related]
2. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
3. Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.
Tomić S; Malenković G; Mujičić E; Šljivo A; Tomić SD
BMC Womens Health; 2024 Apr; 24(1):226. PubMed ID: 38582869
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
6. Advances in the prevention and treatment of breast cancer-related lymphedema.
Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
[TBL] [Abstract][Full Text] [Related]
7. Time trend of breast cancer-related lymphedema according to body mass index.
Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
[TBL] [Abstract][Full Text] [Related]
8. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
[No Abstract] [Full Text] [Related]
10. Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality.
Cheng MH; Ho OA; Tsai TJ; Lin YL; Kuo CF
J Surg Oncol; 2022 Dec; 126(7):1162-1168. PubMed ID: 35960614
[TBL] [Abstract][Full Text] [Related]
11. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study.
Penn IW; Chang YC; Chuang E; Chen CM; Chung CF; Kuo CY; Chuang TY
Support Care Cancer; 2019 Mar; 27(3):991-1000. PubMed ID: 30105666
[TBL] [Abstract][Full Text] [Related]
13. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
[TBL] [Abstract][Full Text] [Related]
14. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
16. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging.
Aldrich MB; Rasmussen JC; DeSnyder SM; Woodward WA; Chan W; Sevick-Muraca EM; Mittendorf EA; Smith BD; Stauder MC; Strom EA; Perkins GH; Hoffman KE; Mitchell MP; Barcenas CH; Isales LE; Shaitelman SF
Breast Cancer Res Treat; 2022 Aug; 195(1):33-41. PubMed ID: 35816269
[TBL] [Abstract][Full Text] [Related]
17. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
18. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.
Gennaro M; Maccauro M; Mariani L; Listorti C; Sigari C; De Vivo A; Chisari M; Maugeri I; Lorenzoni A; Aliberti G; Scaperrotta GP; Caraceni A; Pruneri G; Folli S
Cancer; 2022 Dec; 128(24):4185-4193. PubMed ID: 36259883
[TBL] [Abstract][Full Text] [Related]
20. Weight loss does not decrease risk of breast cancer-related arm lymphedema.
Roberts SA; Gillespie TC; Shui AM; Brunelle CL; Daniell KM; Locascio JJ; Naoum GE; Taghian AG
Cancer; 2021 Nov; 127(21):3939-3945. PubMed ID: 34314022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
